Physician profile
David Bailey Jarrett
NPI 1558438648
$27,772.49
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $95.67 · 2021: $12.70 · 2022: $29.67.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $26,850.39 | 2019-2020 | |
| Smith+Nephew, INC. | $318.43 | 2019 | |
| Janssen Pharmaceuticals, INC | $145.01 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $144.73 | 2019 | |
| Sunovion Pharmaceuticals INC. | $92.81 | 2019-2020 | |
| Neos Therapeutics, LP | $50.01 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $31.94 | 2019 | |
| Abbvie INC. | $29.67 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.91 | 2019-2020 | |
| Adlon Therapeutics L.P. | $27.82 | 2019 | |
| Acadia Pharmaceuticals INC | $27.37 | 2019-2021 | |
| Lundbeck LLC | $14.32 | 2019 | |
| Neurocrine Biosciences, INC. | $11.08 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Jarrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.